Quvadec has acquired Resilux through a cash tender offer and delisting
Quvadec has acquired Resilux NV through a cash tender offer and delisting.
Quvadec is the bidding company controlled by Quva, the investment holding of Pascal Vanhalst, that invests with a vision and intention to create significant and sustainable shareholder value in the long term. The current co-CEOs, Peter and Dirk De Cuyper, will retain a minority stake and remain involved to support Resilux’s further growth. The acquisition fits perfectly into Quva’s strategy and vision given Resilux’s circular business model and proven international track record.
Resilux is an established PET packaging player in the production of preforms and bottles, using patented production and process techniques for various applications. In 2017, the company expanded its core business segment by adding the recycling of used PET bottles to its activities in order to produce high-quality recycled PET (rPET) which can be reused in the food and beverage sector.
Oaklins’ team in Belgium acted as the exclusive financial advisor to the bidder.
Jan Nelissen
CEO, Quva
Talk to the deal team
Pieter Vanhoudt
Oaklins KBC Securities
Related deals
Dolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth
Dolmans Landscaping Group, a leading full-service provider of landscaping services, has welcomed Foreman Capital as a new shareholder. By partnering with Foreman Capital, which has extensive experience in building stronger companies in the maintenance of public spaces, Dolmans can accelerate its growth trajectory across core verticals and further professionalize the business.
Learn moreBackspin has completed a mandatory public tender offer for the shares of Spindox
Backspin S.p.A. has completed a mandatory public tender offer for Spindox S.p.A.
Learn moreCenterbridge Partners has announced a minority interest investment in Pure Cremation
Centerbridge Partners, L.P. has announced a structured minority interest investment in Pure Cremation. The investment includes both loan and equity instruments and is subject to regulatory approval, with completion expected in the first half of 2026.
Learn more